Health Condition 1: A150- Tuberculosis of lung
Conditions
Interventions
Intervention1: LEAFLET(NO DRUG): PROPER LEAFLET REGARDING TREATMENT ADHEARANCE , NUTRITION ,AND QUALITY OF LIFE ANALYSIS
Control Intervention1: control group: only treatment advice given as per guidel
Sponsors
DR SIBANGI MOHANTY
STAGTB
Eligibility
Inclusion criteria
Inclusion criteria: ALL DIAGNOSED Patients of resistant PTB,MDR TB and XDR TB, currently undergoing treatment at PULMONARY MEDICINE,SCBMCH, PTS WILLING TO COMPLY TO STUDY PROTOCOL
Exclusion criteria
Exclusion criteria: EXTRA PULMONARY TB PATIENTS PTS WITH CO-INFECTIONS SUCH AS PHLA,HBV PTS DIAGNOSED WITH CO-MORBIDITIES LIKE CKD,DM,HTN,LIVER FAILURE,CHF DRUGS WHICH CAUSE GI DISTURBANCES,OTOTOXICITY,P.NEUROPATHY,DERMATOLOGICAL DISORDER,RENAL IMPAIRMENT,PHYCHIATRIC DISORDER,VISION PROBLEMS,QT PROLONGATION,SEIZURE,ATHRALGIA,HYPOTHYROIDISM, ELECTROLYTE IMBALANCE, HEPATIC DYSFUNCTION
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| EFFICACY OF IEC GIVEN TO PATIENTS OVER ADHERANCE AND QUALITY OF LIFE IN COMPARISION TO PATIENTS WHO DID NOT RECIEVE IECTimepoint: TO BE ASSESSED EVERY 2 WEEKS UNTILL TREATMENT ENDS | — |
Secondary
| Measure | Time frame |
|---|---|
| IEC IN REDUCING ADR IEC IN IMPROVING DRUG ADHERENCE IMPROVED QOLTimepoint: AT BASELINE VISIT ONCE IN 4 WEEKS | — |
Countries
India
Contacts
Public ContactSIBANGI MOHANTY
SCB MEDICAL COLLGE AND HOSPITAL
Outcome results
None listed